Blue Trust Inc. Sells 159 Shares of Cigna Group $CI

Blue Trust Inc. decreased its stake in Cigna Group (NYSE:CI) by 7.1% during the second quarter, Holdings Channel.com reports. The institutional investor owned 2,086 shares of the health services provider’s stock after selling 159 shares during the quarter. Blue Trust Inc.’s holdings in Cigna Group were worth $690,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in CI. Valeo Financial Advisors LLC increased its holdings in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after buying an additional 3,471,249 shares during the last quarter. Nuveen LLC bought a new position in shares of Cigna Group during the 1st quarter valued at $727,905,000. Price T Rowe Associates Inc. MD grew its holdings in shares of Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the last quarter. GQG Partners LLC grew its holdings in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Cigna Group by 38.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Activity

In other news, insider Brian C. Evanko sold 5,368 shares of the firm’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.70% of the company’s stock.

Cigna Group Trading Down 1.7%

Shares of CI opened at $301.00 on Friday. The stock has a market capitalization of $80.35 billion, a P/E ratio of 16.43, a PEG ratio of 0.88 and a beta of 0.45. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a fifty day simple moving average of $294.68 and a two-hundred day simple moving average of $309.23. Cigna Group has a twelve month low of $256.89 and a twelve month high of $358.88.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, beating the consensus estimate of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were given a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is currently 32.97%.

Analyst Ratings Changes

Several equities analysts recently commented on CI shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a report on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 target price on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Wells Fargo & Company increased their target price on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a report on Tuesday. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Finally, Truist Financial set a $375.00 target price on shares of Cigna Group in a report on Tuesday, September 2nd. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $372.69.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.